We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
-16.98%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$4.68B
AUM Growth
-$1.71B
Cap. Flow
-$462M
Cap. Flow %
-9.88%
Top 10 Hldgs %
25.31%
Holding
149
New
16
Increased
23
Reduced
54
Closed
13

Top Buys

Rank Stock Value
1
DOCS icon
Doximity
DOCS
+$59.6M
2
GTM
ZoomInfo Technologies
GTM
+$19.8M
3
CMS icon
CMS Energy
CMS
+$19.8M
4
GH icon
Guardant Health
GH
+$18.2M
5
LNG icon
Cheniere Energy
LNG
+$15.6M

Top Sells

Rank Stock Value
1
DT icon
Dynatrace
DT
+$112M
2
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$64.6M
3
SMAR
Smartsheet Inc.
SMAR
+$38.2M
4
ROP icon
Roper Technologies
ROP
+$32.9M
5
LRCX icon
Lam Research
LRCX
+$31.8M

Sector Composition

Rank Sector Weight
1 Healthcare 35.3%
2 Technology 26.13%
3 Industrials 16.22%
4 Consumer Discretionary 5.49%
5 Utilities 5.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$165M 3.52%
1,129,100
-505,900
-31% -$64.6M
MTD icon
2
Mettler-Toledo International
MTD
$27.9B
$141M 3.01%
122,500
-4,000
-3% -$5.03M
ARGX icon
3
argenx
ARGX
$54.6B
$121M 2.59%
319,400
-93,100
-23% -$30M
ODFL icon
4
Old Dominion Freight Line
ODFL
$44.2B
$114M 2.44%
890,400
– –
FIVN icon
5
FIVE9
FIVN
$2.12B
$114M 2.43%
1,247,800
-11,700
-0.9% -$1.18M
ASND icon
6
Ascendis Pharma A/S
ASND
$16.5B
$111M 2.38%
1,199,000
-130,432
-10% -$12.3M
PANW icon
7
Palo Alto Networks
PANW
$265B
$110M 2.35%
1,335,822
+128,100
+11% +$11.4M
CTAS icon
8
Cintas
CTAS
$82.7B
$106M 2.26%
1,132,400
-26,000
-2% -$2.53M
CRWD icon
9
CrowdStrike
CRWD
$189B
$103M 2.19%
2,432,400
+8,000
+0.3% +$362K
WCN
10
Waste Connections
WCN
$41.9B
$99.7M 2.13%
804,000
– –
XIFR
11
XPLR Infrastructure LP
XIFR
$1.12B
$96.2M 2.06%
1,296,627
-367,973
-22% -$26.4M
TT icon
12
Trane Technologies
TT
$97.3B
$94M 2.01%
724,000
-17,900
-2% -$2.48M
ROP icon
13
Roper Technologies
ROP
$38.5B
$93.4M 2%
236,700
-75,700
-24% -$32.9M
RXDX
14
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$91.3M 1.95%
3,232,700
– –
IDXX icon
15
Idexx Laboratories
IDXX
$44.1B
$90.2M 1.93%
257,300
-24,400
-9% -$9.95M
DLO icon
16
dLocal
DLO
$4.41B
$89.7M 1.92%
3,415,443
-352,706
-9% -$9.03M
POOL icon
17
Pool Corp
POOL
$6.95B
$86.8M 1.86%
247,100
– –
GTM
18
ZoomInfo Technologies
GTM
$978M
$83.9M 1.8%
2,525,419
+449,419
+22% +$19.8M
KRTX
19
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$78.4M 1.68%
619,400
-128,600
-17% -$14.8M
TTD icon
20
Trade Desk
TTD
$8.59B
$76.5M 1.64%
1,826,685
-212,115
-10% -$11.6M
LOW icon
21
Lowe's Companies
LOW
$118B
$76.4M 1.63%
437,600
-3,284
-0.7% -$633K
GH icon
22
Guardant Health
GH
$20.2B
$67.8M 1.45%
1,681,000
+368,100
+28% +$18.2M
KNBE
23
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
$65.8M 1.41%
4,212,483
+500
+0% +$9.78K
HUBS icon
24
HubSpot
HUBS
$11.9B
$65.2M 1.39%
216,733
-2,000
-0.9% -$730K
APTV icon
25
Aptiv
APTV
$12.3B
$64.1M 1.37%
719,700
– –
1
2 3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, Eventide Asset Management held 149 positions worth $4.68B, down 27% from $6.38B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Eventide Asset Management withdrew a net $462M in Q2 2022, closing 13 positions and reducing 54 holdings. Its most notable exit was Dynatrace, an estimated $112M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Industrials.

Against the trend, Eventide Asset Management opened a new position in Doximity worth $52.7M.

  • Eventide Asset Management's largest Q2 2022 buy was Doximity: 1,512,602 shares worth $52.7M.
  • Eventide Asset Management added most to ZoomInfo Technologies in Q2 2022, an estimated $19.8M increase.
  • Eventide Asset Management's biggest Q2 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $64.6M.
  • Eventide Asset Management fully exited Dynatrace in Q2 2022, selling an estimated $112M.
  • Eventide Asset Management's ten largest holdings make up 25% of its $4.68B portfolio in Q2 2022.
  • Eventide Asset Management opened 16 new positions and closed 13 in Q2 2022.
  • Eventide Asset Management's portfolio value fell 27% quarter-over-quarter to $4.68B.

Based on Eventide Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.